Business Wire

Orbia Fluor & Energy Materials (Koura) Launches New Low-GWP Alternative to R-1234yf for the EU and UK Automotive Aftermarket

Share

Orbia Advance Corporation S.A.B. de C.V.’s (BMV: ORBIA*) Fluor & Energy Materials business today launched Klea ® Edge™ 444A, a direct replacement for R-1234yf, to the EU and U.K. markets. Designed as a higher performing, low global warming potential (GWP) solution for automotive aftermarket applications, the refrigerant meets the European Directive on mobile air conditioning systems (MACs).

Klea® Edge™ 444A provides the industry with a more economical alternative to R-1234yf. It also delivers increased vehicle performance while maintaining ease of use and recovery for service technicians and vehicle owners.

“Innovations like Klea® Edge™ 444A are impactful to Orbia’s greater purpose of advancing life around the world and are crucial to decarbonization and the energy transition,” said Shawn Shorrock, Global Vice President, Refrigerants, Orbia Fluor & Energy Materials. “Leveraging more than 50 years of experience delivering high-performing refrigerant solutions, we continue to evolve our business and product portfolio with low-GWP refrigerants that create progress towards our global climate impact goals.”

Klea® Edge™ 444A delivers the following key benefits:

  • Colder air, faster: Third-party lab data confirms that R-444A pulls down cabin temperature up to four minutes faster than R-1234yf.*
  • Increased vehicle performance: R-444A's higher energy efficiency can enable internal combustion engine vehicles to see improved fuel economy while electric vehicles may experience extended range.
  • Diversification in market options: R-444A is compatible with R-1234yf and its components.
  • An economical alternative: R-444A is a competitively priced direct replacement for R-1234yf.**
  • Ease of use and recovery: As a direct replacement, service technicians and vehicle owners can rely on the same servicing equipment, gauges and tools to replace R-1234yf with R-444A.
  • Meets evolving regulations: Complies with current and new regulations, including those that restrict refrigerants with a GWP greater than 150.
  • REACH approved: R-444A is authorized for use in automotive aftermarket applications under U.K. and EU standards.
  • TEXA Certified: Any R-1234yf TEXA A/C cart is compatible and certified to be used with R-444A in the EU. TEXA is one of the largest A/C manufacturers in the EU, and other manufacturer approvals are in progress.

“With increasing environmental regulations in the EU and U.K. for refrigerants, we’re committed to leading the industry with solutions that lower the environmental impact significantly without compromising on performance,” said Michael Mukai, Global Market Management Director, Refrigerants, Orbia Fluor & Energy Materials.

Orbia Fluor & Energy Materials’ strong and growing product portfolio for the global automotive aftermarket sector is a testament to the organization’s commitment to decarbonization. In addition to Klea® Edge™ R-444A, it includes industry award-winning Klea® 456A, a lower GWP direct replacement for R-134a that delivers the same energy efficiency while also providing a 50% reduction in GWP.

For more information on Orbia Fluor & Energy Materials’ next generation solutions and products for the automotive aftermarket, visit: www.kouraglobal.com/applications/refrigerants.

* Independent test lab data shows an improvement in pull down times.

** Based on market conditions in EU/U.K. July 2024

About Orbia

Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) is a company driven by a shared purpose: to advance life around the world. Orbia operates in the Polymer Solutions (Vestolit and Alphagary), Building & Infrastructure (Wavin), Precision Agriculture (Netafim), Connectivity Solutions (Dura-Line) and Fluor & Energy Materials (Koura) sectors. The five Orbia business groups have a collective focus on expanding access to health and well-being, reinventing the future of cities and homes, ensuring food, water and sanitation security, connecting communities to information and enabling the energy transition with basic and advanced materials, specialty products and innovative solutions. Orbia has a global team of over 24,000 employees, commercial activities in more than 100 countries and operations in over 50, with global headquarters in Boston, Mexico City, Amsterdam and Tel Aviv. The company generated $8.2 billion in revenue in 2023. To learn more, visit: orbia.com

About Orbia Fluor & Energy Materials (Koura)

Orbia’s Fluor & Energy Materials business (branded as Koura) is a global leader in the development, manufacture and supply of Fluoroproducts that play a fundamental role in enhancing everyday lives and shortening the path to a sustainable, circular economy. Backed by over 35 years of experience, Orbia Fluor & Energy Materials’ products are used in a vast range of applications including electric vehicles and energy storage, urban and rural infrastructure, indoor climate management, food and medicine refrigeration and even in treating respiratory conditions through the development of healthy and innovative low-GWP propellants for metered dose inhalers. Orbia Fluor & Energy Materials has 1,600 employees and 13 manufacturing facilities worldwide, serving 60 countries through a global sales and distribution network.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240925405075/en/

Contacts

Katherine Hogue
PR and Media Manager Orbia
katherine.hogue@orbia.com
+1 (224) 496-0568

Pamela McGowan
Global Marketing Communications Lead,
Refrigerants, Orbia Fluor & Energy Materials
pam.mcgowan@orbia.com
+1 330-810-4918

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

You Up? Grindr’s “Right Now” Goes Global30.5.2025 16:00:00 EEST | Press release

Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded people without wasting time on mismatched expectations. The response to our initial March launc

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 15:00:00 EEST | Press release

Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative financing approaches to manage the costs of treatment and care. “Despite CAR T-cell therapy being available in the United States for nearly seven years in large B-cell lymphoma, only approximately two out of 10 eligible patients with some advanced blood cancers ever receive CAR T-cell therapy,” said Miguel Perale

Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 12:17:00 EEST | Press release

In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha

FDA Grants De Novo Clearance for Reflow Medical's Spur ® Peripheral Retrievable Stent System30.5.2025 07:08:00 EEST | Press release

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529610368/en/ The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel complia

Black Forest Labs Launches FLUX.1 Kontext, a Breakthrough in Context-aware Image Generation and Editing29.5.2025 23:27:00 EEST | Press release

Black Forest Labs, Europe’s fast-rising frontier AI research lab, announced today the release of FLUX.1 Kontext, a new suite of image generation models that introduce powerful in-context generating and editing capabilities. Kontext enables users to generate, retouch, and iteratively refine images from both text and visual inputs, without the need for finetuning or complex editing workflows. FLUX.1 Kontext is designed for creators, developers, and enterprises seeking precision and creative control. The model can understand and extract visual concepts from images, maintain stylistic and character consistency across multiple scenes, and apply localized edits with exceptional fidelity. This enables seamless visual storytelling, fast ideation, and highly targeted content generation, all at inference speeds up to 8x faster than leading alternatives. "FLUX.1 Kontext represents a fundamental shift from traditional editing approaches by unifying image generation and editing in a single flow mat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye